Improving tau clearance in Alzheimer's disease by reducing a specific protein
Official title: Enhancing proteasomal activity and tau clearance via USP14 reduction in Alzheimer's Disease mouse models
Funded at Washington University · NIH-10995921 · Data updated 2026-11-12
This study is looking at ways to help people with Alzheimer's disease by finding a way to help their brains get rid of harmful tau proteins that can cause memory problems, using a special technique to boost the brain's natural cleanup system.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Washington University NIH-funded |
| Lab location | 1 site (Saint Louis, United States) |
| Project start | September 16, 2024 |
| Project end | September 15, 2027 |
| Funding year | 2024 |
| Award (this year) | $34,623 |
| NIH project number | 1F31AG084257-01A1 |
| Project ID | NIH-10995921 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals diagnosed with Alzheimer's disease who exhibit symptoms related to tau pathology.
✕Less likely to help
Patients with other forms of dementia that do not involve tau pathology may not benefit from this research.
What this research studies
This research focuses on Alzheimer's disease, a condition that leads to memory loss and is a major cause of dementia. The study aims to enhance the brain's ability to clear tau proteins, which accumulate and contribute to cognitive decline. Researchers will use a technique involving antisense oligonucleotides to reduce the levels of a protein called Usp14, which hinders the degradation of tau. By increasing the activity of the proteasome, the brain's waste disposal system, this approach seeks to lower tau levels and potentially slow down neurodegeneration.
Why it matters
Potential benefit: If successful, this research could lead to new therapies that effectively reduce tau accumulation and improve cognitive function in Alzheimer's patients.
How similar studies have gone: While the approach of targeting Usp14 for tau clearance is innovative, similar strategies using antisense oligonucleotides have shown promise in other neurological conditions.
Where this research is happening
-
Washington University
Saint Louis, United States Active
Researchers
- Principal investigator: Hu, Miwei — Washington University
- Study coordinator: Hu, Miwei
Related research
Other NIH-funded projects on the same topics.
-
Understanding how brain activity changes may drive Alzheimer’s disease progression in a mouse model
Researchers are testing how changes in brain signals and protein cleanup processes affect the development of Alzheimer’s disease in mice.
-
Thiamine-boosting therapy for Alzheimer’s: understanding how benfotiamine may reduce harmful AGE in DP patients
A medication-based approach using high-dose vitamin B1 (benfotiamine) is studied to help people with Alzheimer's by reducing harmful sugar-related molecules.
-
Non-invasive tears biomarker for early Alzheimer's in LMICs
A low-cost, tear-based biomarker approach aims to detect early Alzheimer’s disease in older adults in Peru and similar settings.
-
Turning APOE4 into protective APOE2 or APOE3Christchurch to help with Alzheimer’s
A patient-facing explanation of a treatment idea that aims to change a genetic risk factor for Alzheimer's disease in the brain.
-
Telomerase in Alzheimer’s Disease: how aging biology could influence memory and brain health
Researchers are exploring a new brain-aging mechanism linked to telomerase, with potential to slow or modify Alzheimer’s disease in people and improve cognitive function.
-
Biomarkers of Alzheimer’s Disease: Sensory, Motor, and Cognitive Clues
Researchers are testing simple sensory and movement tasks to find early signs of Alzheimer’s disease so they can diagnose and treat people sooner.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.